Not only that, but several studies have also found that OX40 (Figure 2) is predominantly expressed on the tumor‐infiltrated FOXP3+ Tregs of cutaneous squamous cell carcinoma208 and peripheral FOXP3+ Tregs of patients with breast cancer.209. Here, FOXP3 is linked to breast carcinoma.